2022-12-24 00:00
經濟3.0 徐家健
從銀髮醫療到銀髮經濟
因為一宗監管風暴,一口氣寫了〈NMN抗衰老卻抗不過監管?〉等幾篇關於「不老藥」NMN的經濟文章。
美國食品及藥物管理局(FDA)的藥物監管是否過嚴,芝大老師莫里根最近總結半個世紀的研究:
Using a simple and versatile industry model and historical data on entry, I find that easing generic restrictions discourages innovation, but this welfare cost is more than offset by consumer benefits from ...
(節錄)全文共1830字